Sourced from:Manufacturer Authorized Distributor
Quick Summary
Paclitero 260mg Injection
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹1745
MRP: ₹9815.63
(You Save ₹8070.63)
1 VIAL(s) OF 43.4ML
Sourced from:Manufacturer Authorized Distributor
82% OFF
₹1745
MRP: ₹9,815.63
Inclusive of all taxes
82% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Dutaxel 260mg Injection
SAMARTH LIFE SC...
₹ 784.00/injection
55% cheaper
Kansure 260mg Injection
KHANDELWAL LABO...
₹ 863.00/injection
50% cheaper
Taxeleon 260mg Injection
NEON LABORATORI...
₹ 937.00/injection
46% cheaper
Pacliarc 260mg Injection
DELARC PHARMACE...
₹ 1125.00/injection
35% cheaper
Introduction to Paclitero 260mg Injection
Paclitero 260 mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count.
Paclitero 260 mg is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.
Uses of Paclitero 260mg Injection
- Ovarian cancer
- Breast cancer
- Non-small cell lung cancer
- AIDS-related Kaposi’s sarcoma
Therapeutic Effects of Paclitero 260mg Injection
Paclitero 260 mg Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.
Interaction of Paclitero 260mg Injection with other drugs
Inform your doctor about any prescribed medicines, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications may interact with Paclitero 260 mg injection and cause undesirable side effects.
More Information about Paclitero 260mg Injection
- Keep Paclitero 260 mg Injection out of sight and reach of children.
- Do not store above 25°C.
How to consume Paclitero 260mg Injection
It will be given to you by a doctor or nurse. Do not self-administer. Your doctor will decide the dose and dosage of the Paclitero 260 mg injection.
Safety Advice for Paclitero 260mg Injection
Breast Feeding
Stop breastfeeding during the treatment with Paclitero 260 mg Injection. Consult your doctor for potential risks.
Alcohol
It is unsafe to consume alcohol with Paclitero 260 mg Injection.
Liver
It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking Paclitero 260 mg Injection.
Lungs
It is unknown whether Paclitero 260 mg injection can be given to patients with lung disorders. Please consult your physician for more advice.
Driving
The alcohol present in Paclitero 260 mg Injection may affect your ability to drive. Avoid driving if you feel unwell.
Pregnancy
Paclitero 260 mg Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this Injection.
Side Effects of Paclitero 260mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious:
- Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
- Severe diarrhea
- Severe stomach pain
Common:
- Anemia, feeling tired
- Hair loss
- Burning, tingling, or numbness in your feet or hands
- Muscle and joint pain
- Vomiting, nausea
- Mouth or lip sores
- Infections
- Swelling of hands, feet, and face
- Bleeding
- Irritation at the injection site
- Low blood pressure
Word of Advice
Inform the doctor if the patient is allergic to this medication, liver, heart conditions, and other medication taken for different medical conditions before taking this medicine. Liver, blood pressure, and blood count should be monitored while taking this medication. Don't take this medication if the patient is planning for pregnancy or during pregnancy and in breastfeeding mothers, as it causes harmful effects on developing babies. Avoid driving and handling heavy machinery after taking this medication, as it can affect concentration and alertness.
FAQs about Paclitero 260mg Injection
Q1.
Can Paclitero 260 mg Injection cause hair loss?
Yes, the common side effects of this medication are hair loss, and inform the doctor if there is excessive hair loss.
Q2.
How does Paclitero 260 mg Injection work?
It works by interfering with the microtubule structures, which help the cancer cells to divide and multiply, and it slows the growth of cancer cells.
Q3.
Does Paclitero 260 mg Injection cause liver problems?
Yes, this medication is contraindicated in patients with severe liver disorders. Inform the doctor before starting this medication.
Q4.
Can I take Paclitero 260 mg Injection while driving?
It is unsafe to use this medication while driving because it can cause dizziness, lack of concentration, and alertness.
Q5.
What are the side effects of Paclitero 260 mg Injection?
The common side effects of Paclitero 260 mg injection are anemia, hair loss, numb feet or hands, muscle pain, nausea, vomiting, infections, swelling, bleeding, irritation on the injection site, and low blood pressure.
Q6.
Can I take Paclitero 260 mg Injection during pregnancy?
It is unsafe to take this medication during pregnancy as it causes harmful effects on the developing baby. Inform the doctor if the patient is planning for pregnancy before starting this medication.
Fact Box of Paclitero 260mg Injection
Molecule name: Paclitaxel | Therapeutic class: Anti-Microtubular Agents |
Pharmacological class: Anti-Neoplastics | Indications: 1. Ovarian cancer 2. Breast cancer 3. Non-small cell lung cancer 4. AIDS-related Kaposi’s sarcoma |
References
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707 - 1709.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865.
- Hospira UK Limited, Electronic medicines compendium (emc), [ Revised on March 2020] [ Accessed on 22nd June 2021], https://www.medicines.org.uk/emc/files/pil.3891.pdf
- Bristol-Myers Squibb Company, US Food and Drug Administration, [ Revised on April 2011] [ Accessed on 22nd June 2021], https://www.accessdata.fda.gov/drugsatfda_docs/lab el/2011/020262s049lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Guruvigneshwari M.
M. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
